salix pharmaceuticals ltd (XP2:Berlin)
Transactions by SALIX PHARMACEUTICALS LTD (XP2) in the last 6 months
Salix Pharmaceuticals Ltd. (NasdaqGS:SLXP) entered into a definitive agreement to acquire the assets of Cosmo Technologies Ltd from Cosmo Pharmaceuticals S.p.A. (SWX:COPN) for $2.6 billion in stock on July 8, 2014. Under the terms of the transaction, Cosmo Technologies stake in Salix is valued at $2.6 billion and $42 million of milestone payments in 2015, of which $21 million will be payable at last patient in MB trial and $21 million at start of the construction at ...
Procopio Cory Hargreaves & Savitch LLP
Salix Pharmaceuticals Ltd. (NasdaqGS:SLXP) entered into an agreement to acquire Exclusive Worldwide Rights to RHB-106 Encapsulated Bowel Preparation from RedHill Biopharma Ltd. for $12 million on February 27, 2014. Under the terms of the transaction, Salix will make an upfront payment of $7 million and $5 million in subsequent milestone payments to RedHill.
|Alkermes PLC||$42.97 USD||+0.21|
|Cubist Pharmaceuticals Inc||$61.05 USD||+0.15|
|Jazz Pharmaceuticals Plc||$139.73 USD||0.00|
|Lupin Ltd||1,165 INR||-16.35|
|Santen Pharmaceutical Co Ltd||¥6,090 JPY||+10.00|
|View Industry Companies|